{
  "ptid_time": "013_S_4616_2012-04-19",
  "img_path": "/data/qiuhui/data/adni/images/013_S_4616/2012-04-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 89,162 mm³, 89.6% above the reference mean. With a Z-score of 2.60 (99.5th percentile), this represents significant enlargement; hippocampal volume measures 6,988 mm³, 0.3% above the reference mean. With a Z-score of 0.02 (51.0th percentile), this represents normal volume ; whole brain volume measures 1,125,560 mm³, 9.4% above the reference mean. With a Z-score of 1.23 (89.0th percentile), this represents mild enlargement. ",
  "text_data": "Age is 84.8 years. Gender is Male. Education: 18 years. Handedness: Right. Race: More than one race. Medical history: Endocrine-Metabolic; Hematopoietic-Lymphatic; Renal-Genitourinary; Smoking; Malignancy; Major Surgical Procedures. MMSE: 29.0. MoCA: 23.0. Logical Memory: 15.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.39 SUVR (significant elevated); Amyloid beta: 897.80 pg/mL (normal ); Total tau: 200.70 pg/mL (normal ); Phosphorylated tau: 20.49 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant ventricular enlargement (indicative of brain atrophy) but normal hippocampal volume and mild whole brain enlargement. Cognitive testing reveals a high MMSE (29/30) but borderline MoCA (23/30), suggesting possible mild cognitive deficits. Biomarkers (Aβ, T-tau, P-tau) are normal, but AV45 (amyloid PET) is elevated, suggesting amyloid pathology despite normal CSF markers.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to conflicting biomarker results—normal CSF but elevated AV45—and borderline MoCA with preserved MMSE)",
  "timestamp": "2025-07-25T23:34:18.330780"
}